Cargando…
Metabolomics analysis identifies a lipidomic profile in treatment-naïve juvenile dermatomyositis patients vs healthy control subjects
OBJECTIVES: To perform an exploratory study to identify a JDM serum metabolic profile that differs from healthy controls (HCs) and responds to immunosuppressive treatment. METHODS: Blood was collected from 9 HCs and 10 patients diagnosed with probable (n = 4) or definite (n = 6) JDM based on the cri...
Autores principales: | Dvergsten, Jeffrey A, Reed, Ann M, Landerman, Lawrence, Pisetsky, David S, Ilkayeva, Olga, Huffman, Kim M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996785/ https://www.ncbi.nlm.nih.gov/pubmed/34185053 http://dx.doi.org/10.1093/rheumatology/keab520 |
Ejemplares similares
-
Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment
por: Pinotti, Caitlan S., et al.
Publicado: (2023) -
Maternal microchimerism in muscle biopsies from children with juvenile dermatomyositis
por: Ye, Yi, et al.
Publicado: (2012) -
Gene Expression Profiles of Treatment Response and Non‐Response in Children With Juvenile Dermatomyositis
por: Stingl, Cory, et al.
Publicado: (2022) -
Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2021) -
Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)